| " Smoking cessation in schizophrenia": Reply. AE Evins, C Cather, T Deckersbach, O Freudenreich, DC Henderson, ... Lippincott Williams & Wilkins, 2007 | | 2007 |
| “Poor Insight”: A capacity perspective on treatment refusal in serious mental Illness N Kontos, O Freudenreich, J Querques Psychiatric Services 67 (11), 1254-1256, 2016 | 8 | 2016 |
| “Professionalism, Physicianhood, and Psychiatric Practice”: Conceptualizing and implementing a senior psychiatry resident seminar in reflective and inspired doctoring O Freudenreich, N Kontos Psychosomatics 60 (3), 246-254, 2019 | 9 | 2019 |
| (21) Motivating and Mobilizing: Leveraging Psychiatric Providers and Settings to Maximize Vaccinations among Individuals with Serious Mental Illness C Lim, M Van Alphen, S Maclaurin, T Wright, O Freudenreich Journal of the Academy of Consultation-Liaison Psychiatry 63, S122, 2022 | | 2022 |
| (PO-039) Expanding the Role of Psychiatrists to Increase COVID-19 Vaccination Rates in Clozapine-treated Patients with Serious Mental Illness: A Quality Improvement Project C Lim, O Freudenreich, M Van Alphen, S Maclaurin Journal of the Academy of Consultation-Liaison Psychiatry 63, S19, 2022 | | 2022 |
| 4 Ways to help your patients with schizophrenia quit smoking K Cieslak, O Freudenreich Current Psychiatry 17 (2), 28-30, 2018 | 1 | 2018 |
| 42 Antipsychotic Drugs O Freudenreich, DC Goff, DC Henderson | | |
| 5 questions guide care of patients with psychosis O Freudenreich, J Querques, N Kontos Current Psychiatry 5 (8), 124, 2006 | | 2006 |
| 5 Schizophrenia Spectrum and Other Psychotic Disorders D ONGUR, F BENES, O FREUDENREICH | | |
| 52. Abnormal Anterior Insula Activity During Fear Generalization in Schizophrenia L Tuominen, S DeCross, S Nasr, E Boeke, R Wolthusen, R Tootell, ... Schizophrenia Bulletin 43 (Suppl 1), S27, 2017 | 2 | 2017 |
| A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia AE Evins, C Cather, MA Culhane, A Birnbaum, J Horowitz, E Hsieh, ... Journal of clinical psychopharmacology 27 (4), 380-386, 2007 | 210 | 2007 |
| A case of dramatic improvement of severe tardive dyskinesia after switch to aripiprazole HE Brown, AW Flaherty, DC Goff, O Freudenreich The Primary Care Companion for CNS Disorders 13 (6), 26760, 2011 | 5 | 2011 |
| A Case of Undetected Seizure Disorder That Exacerbated Catatonia and Treatment-Resistant Schizophrenia: Comprehensive Evaluation Is Key C Lim, AL Donovan, GK Harrold, O Freudenreich The Primary Care Companion for CNS Disorders 24 (6), 44756, 2022 | | 2022 |
| A case report of confusional psychosis with abrupt onset and rapid resolution of symptoms. B Legesse, O Freudenreich, E Murray, B Price Psychosomatics 52 (5), 468-471, 2011 | 9 | 2011 |
| A comparison of the effects of quetiapine and olanzapine on glucose metabolism in patients with schizophrenia D Henderson, PM Copeland, CP Borba, DD Nguyen, AE Evins, H Zhang, ... EUROPEAN NEUROPSYCHOPHARMACOLOGY 15, S494-S495, 2005 | | 2005 |
| A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia AE Evins, C Cather, T Deckersbach, O Freudenreich, MA Culhane, ... Journal of clinical psychopharmacology 25 (3), 218-225, 2005 | 252 | 2005 |
| A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain DC Henderson, PM Copeland, TB Daley, CP Borba, C Cather, ... American Journal of Psychiatry 162 (5), 954-962, 2005 | 174 | 2005 |
| A double-blind, randomized trial comparing clozapine treatment within three distinct serum level ranges in patients with refractory chronic schizophrenia JP McEvoy, C VanderZwaag, M McGee, O Freudenreich, WH Wilson, ... Schizophrenia Research 2 (18), 127, 1996 | 3 | 1996 |
| A double‐blind, placebo‐controlled trial of rosiglitazone for clozapine‐induced glucose metabolism impairment in patients with schizophrenia DC Henderson, X Fan, B Sharma, PM Copeland, CP Borba, R Boxill, ... Acta psychiatrica scandinavica 119 (6), 457-465, 2009 | 49 | 2009 |
| A double‐blind, placebo‐controlled trial of sibutramine for clozapine‐associated weight gain DC Henderson, X Fan, PM Copeland, CP Borba, TB Daley, DD Nguyen, ... Acta Psychiatrica Scandinavica 115 (2), 101-105, 2007 | 75 | 2007 |
